• Cocrystal Pharma director Phillip Frost reported an indirect purchase of 10,000 common shares at USD 0.98.
• Frost’s indirect stake held via Frost Gamma Investments Trust rose to 1,993,551 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036396), on August 06, 2026, and is solely responsible for the information contained therein.